ECSP088930A - Derivados de benzoxazol y benzotiazol como ligandos de - Google Patents
Derivados de benzoxazol y benzotiazol como ligandos deInfo
- Publication number
- ECSP088930A ECSP088930A EC2008008930A ECSP088930A ECSP088930A EC SP088930 A ECSP088930 A EC SP088930A EC 2008008930 A EC2008008930 A EC 2008008930A EC SP088930 A ECSP088930 A EC SP088930A EC SP088930 A ECSP088930 A EC SP088930A
- Authority
- EC
- Ecuador
- Prior art keywords
- ligandos
- benzotiazol
- benzoxazol
- derivatives
- receptor
- Prior art date
Links
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 title 1
- 108091005435 5-HT6 receptors Proteins 0.000 abstract 1
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
Abstract
La presente invención suministra un compuesto de fórmula I y el uso de éste para el tratamiento de un trastorno del sistema nervioso central relacionado con o afectado por el receptor 5-HT6.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80999606P | 2006-06-01 | 2006-06-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP088930A true ECSP088930A (es) | 2009-01-30 |
Family
ID=38668755
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2008008930A ECSP088930A (es) | 2006-06-01 | 2008-12-01 | Derivados de benzoxazol y benzotiazol como ligandos de |
Country Status (17)
Country | Link |
---|---|
US (1) | US7501421B2 (es) |
EP (1) | EP2024348A2 (es) |
JP (1) | JP2009538909A (es) |
KR (1) | KR20090023641A (es) |
CN (1) | CN101490022A (es) |
AR (1) | AR061147A1 (es) |
AU (1) | AU2007255041A1 (es) |
BR (1) | BRPI0712444A2 (es) |
CA (1) | CA2659701A1 (es) |
CR (1) | CR10474A (es) |
EC (1) | ECSP088930A (es) |
IL (1) | IL195590A0 (es) |
MX (1) | MX2008015328A (es) |
NO (1) | NO20085045L (es) |
PE (1) | PE20080707A1 (es) |
TW (1) | TW200804310A (es) |
WO (1) | WO2007142904A2 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2882797T3 (es) * | 2009-04-02 | 2021-12-02 | Merck Serono Sa | Inhibidores de dihidroorotato deshidrogenasa |
KR101250606B1 (ko) * | 2011-01-24 | 2013-04-03 | 이화여자대학교 산학협력단 | 5-ht6 수용체 억제 작용을 갖는 신규한 벤조티아졸 및 벤즈이소티아졸유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 |
ES2714705T3 (es) * | 2013-07-10 | 2019-05-29 | Meiji Seika Pharma Co Ltd | Inhibidor de PDE4 novedoso |
CA2953004C (en) | 2014-07-08 | 2023-02-21 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7582635B2 (en) * | 2002-12-24 | 2009-09-01 | Purdue Pharma, L.P. | Therapeutic agents useful for treating pain |
GB0422263D0 (en) * | 2004-10-07 | 2004-11-10 | Glaxo Group Ltd | Novel compounds |
-
2007
- 2007-05-23 PE PE2007000635A patent/PE20080707A1/es not_active Application Discontinuation
- 2007-05-25 WO PCT/US2007/012569 patent/WO2007142904A2/en active Application Filing
- 2007-05-25 EP EP07777299A patent/EP2024348A2/en not_active Withdrawn
- 2007-05-25 MX MX2008015328A patent/MX2008015328A/es not_active Application Discontinuation
- 2007-05-25 BR BRPI0712444-9A patent/BRPI0712444A2/pt not_active Application Discontinuation
- 2007-05-25 CN CNA2007800261442A patent/CN101490022A/zh active Pending
- 2007-05-25 AU AU2007255041A patent/AU2007255041A1/en not_active Abandoned
- 2007-05-25 TW TW096118646A patent/TW200804310A/zh unknown
- 2007-05-25 JP JP2009513221A patent/JP2009538909A/ja not_active Withdrawn
- 2007-05-25 KR KR1020087031621A patent/KR20090023641A/ko not_active Application Discontinuation
- 2007-05-25 CA CA002659701A patent/CA2659701A1/en not_active Abandoned
- 2007-05-31 AR ARP070102364A patent/AR061147A1/es unknown
- 2007-05-31 US US11/809,424 patent/US7501421B2/en not_active Expired - Fee Related
-
2008
- 2008-11-27 IL IL195590A patent/IL195590A0/en unknown
- 2008-12-01 CR CR10474A patent/CR10474A/es not_active Application Discontinuation
- 2008-12-01 EC EC2008008930A patent/ECSP088930A/es unknown
- 2008-12-03 NO NO20085045A patent/NO20085045L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20085045L (no) | 2008-12-12 |
WO2007142904A2 (en) | 2007-12-13 |
KR20090023641A (ko) | 2009-03-05 |
MX2008015328A (es) | 2008-12-12 |
JP2009538909A (ja) | 2009-11-12 |
TW200804310A (en) | 2008-01-16 |
CR10474A (es) | 2009-01-07 |
US7501421B2 (en) | 2009-03-10 |
US20070281945A1 (en) | 2007-12-06 |
EP2024348A2 (en) | 2009-02-18 |
BRPI0712444A2 (pt) | 2012-06-05 |
IL195590A0 (en) | 2009-09-01 |
PE20080707A1 (es) | 2008-05-22 |
CN101490022A (zh) | 2009-07-22 |
WO2007142904A3 (en) | 2008-02-07 |
AU2007255041A1 (en) | 2007-12-13 |
AR061147A1 (es) | 2008-08-06 |
CA2659701A1 (en) | 2007-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP055535A (es) | Derivados de 1-heterociclialquil-3-sulfonilazaindol o azaindol como ligandos de 5-hidroxitriptamina-6 | |
CO6300951A2 (es) | Derivados de azaciclilisoquinolinona e- isoindolinona como antagonistas de la histamina-3 | |
CO6300955A2 (es) | Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina -3 | |
ECSP055536A (es) | Derivados de 1-heterociclilalquil-3-sulfonilindol o indazol como ligandos de 5-hidroxitriptamina-6 | |
CR20150296A (es) | Novedosos derivados de bencimidazol como antagonistas de ep4 | |
CR10309A (es) | "compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1" | |
ECSP12012326A (es) | Derivados de aminopirimidina como moduladores de la lrrk2 | |
ECSP13012611A (es) | Derivados de pirazol-aminopirimidina como moduladores de la lrrk2 | |
GT200600030A (es) | 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2 | |
UY30572A1 (es) | N-(1-ftalazin-1-il-piperidin-4-il)-amidas como moduladores del receptor ep2 | |
CR10243A (es) | "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos" | |
TW200800958A (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
PA8790101A1 (es) | Derivados de aminoalquilazol como antagonistas de histamina-3 | |
ECSP088176A (es) | Derivados de azinil-3-sulfonilindazol como ligandos de5-hidroxitriptamina-6 | |
CR9734A (es) | Derivados de 3-sulfonilindazol sustituido como ligandos de 5-hidroxitriptamina-6 | |
PA8781601A1 (es) | " derivados de azaciclilbenzamida como antagonistas de histamina-3 | |
ECSP11011473A (es) | Antagonistas de ccr3 de arilsulfonamida 2, 5- disustituída | |
CO6341625A2 (es) | Derivados de indol como agentes anticáncer | |
CL2008002767A1 (es) | Compuestos derivados de heterociclico triciclico; composicion farmaceutica; y su uso para el tratamiento de un trastorno mediado por serotonina tal como obesidad, esquizofrenia y disfuncion cognitiva. | |
ECSP088930A (es) | Derivados de benzoxazol y benzotiazol como ligandos de | |
UY31646A1 (es) | Uso de fenilimidazolidinas sustituidas para producir medicamentos para el tratamiento del síndrome metabólico | |
DOP2007000121A (es) | Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para su preparación, medicamentos que comprenden estos compuestos y su uso | |
ECSP067096A (es) | Metabolitos de indolilalquilamina como ligandos 5-hidroxitriptamina-6 | |
ECSP088789A (es) | Derivados de sulfonil-3-heterociclilindazol como ligandos de 5-hidroxitriptamina-6 | |
CU20100047A7 (es) | Derivados de azaciclilisoquinolinona e-isoindolinona como antagonistas de la histamina-3 |